Blirt

Gdansk, Poland Founded: 2008 • Age: 18 yrs Acquired By Qiagen
Specialty enzymes for nucleic acid purification and sequencing are produced.

About Blirt

Blirt is a Healthcare company based in Gdansk (Poland) founded in 2008 by Marian Popinigis, and was acquired by Qiagen in May 2022. Specialty enzymes for nucleic acid purification and sequencing are produced. Its chief executive, as recorded, is Piotr Lassota. Blirt offers products and services including Proteinase K and RNase Inhibitor. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is BLIRT S.A.

Company details

BLIRT was established in 2008 in Gdansk, Poland, within the biotechnology sector. Specialty enzymes used in nucleic acid purification and sequencing are manufactured by the company. Molecular biology kits are supplied alongside these products. Protein production services are offered, encompassing the design of expression systems for commercial applications. Operations remain focused on enzyme and kit development in Europe.

  • Headquarters Gdansk, Poland
  • Founders Marian Popinigis
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website blirt.eu
  • Social LinkedIn
  • Acquired by Qiagen (May 2022)
  • Legal Name Blirt S.A.
Key Metrics

Products & Services of Blirt

Blirt offers a comprehensive portfolio of products and services, including Proteinase K and RNase Inhibitor.

Proteinase K
Enzyme

High-demand enzyme for protein digestion in molecular biology assays

RNase Inhibitor
Enzyme Inhibitor

Protects RNA from degradation during biological research applications

Investors in Blirt

Blirt has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Products and reagents for molecular diagnostic assays are supplied.
1984qiagen.comHilden, Germany
Premium access

Investor details for Blirt

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Blirt

2 people are tracked at Blirt (2 in leadership).

NameRoleGroup
Marian Popinigis
Founder & Board MemberLeadership
Piotr Lassota
CEO & PresidentLeadership
Premium access

Complete people profiles for Blirt

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Blirt

2 dated milestones of Blirt across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Blirt is founded.
  2. Exit Acquired by Qiagen.

Web traffic of Blirt

The website of Blirt (blirt.eu) receives about 4.7K visits a month and ranks #5,112,363 among all websites worldwide, #5,869 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    4.7K

    ▲ 22.6% vs previous month

  • Unique visitors
    1.8K

    per month

  • Global rank
    #5,112,363

    among all websites

  • Category rank
    #5,869

    Health · Biotechnology and Pharmaceuticals

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Blirt

Premium access

Complete news archive for Blirt

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Blirt

Blirt was founded in 2008.

Blirt is headquartered in Gdansk, Poland. It is registered at Gdansk, Pomeranian Voivodeship, Poland.

Piotr Lassota is the CEO of Blirt, as recorded in our data.

BLIRT was established in 2008 in Gdansk, Poland, within the biotechnology sector. Specialty enzymes used in nucleic acid purification and sequencing are manufactured by the company. Molecular biology kits are supplied alongside these products. Protein production services are offered, encompassing the design of expression systems for commercial applications. Operations remain focused on enzyme and kit development in Europe.

Blirt offers Proteinase K and RNase Inhibitor.

Blirt has 1 investor. Key investors include Qiagen.

Blirt operates through Blirt S.A..

Yes. Blirt was acquired by Qiagen in May 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available